George Melko
General Counsel at TYRA BIOSCIENCES, INC.
Profile
Dr. George Melko is a Vice President-Regulatory Affairs at Tyra Biosciences, Inc. Dr. Melko was previously employed as a Vice President-Regulatory Affairs by Aptose Biosciences, Inc., a Vice President-Regulatory Affairs by Tessa Therapeutics Ltd, and a Vice President-Regulatory Affairs by Tmunity Therapeutics, Inc.
George Melko active positions
| Companies | Position | Start |
|---|---|---|
| TYRA BIOSCIENCES, INC. | General Counsel | - |
Former positions of George Melko
| Companies | Position | End |
|---|---|---|
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | General Counsel | - |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | General Counsel | - |
| APTOSE BIOSCIENCES INC. | General Counsel | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- George Melko
